Celltrion
068270.KS
#709
Rank
NZ$49.61 B
Marketcap
$241.41
Share price
3.11%
Change (1 day)
7.99%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$4.35 Billion

According to Celltrion 's latest financial reports the company's total liabilities are NZ$4.35 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$2.02 B1.13%
2021-12-31NZ$1.99 B-1.66%
2020-12-31NZ$2.03 B60.34%
2019-12-31NZ$1.26 B4.5%
2018-12-31NZ$1.21 B3.89%
2017-12-31NZ$1.16 B18.41%
2016-12-31NZ$0.98 B-15.5%
2015-12-31NZ$1.16 B2.71%
2014-12-31NZ$1.13 B10.38%
2013-12-31NZ$1.02 B28.69%
2012-12-31NZ$0.79 B42.48%
2011-12-31NZ$0.56 B29.92%
2010-12-31NZ$0.43 B32.02%
2009-12-31NZ$0.32 B-15.63%
2008-12-31NZ$0.38 B689.12%
2007-12-31NZ$49.14 M